Literature DB >> 12217421

Cloning and characterization of murine neuromedin U receptors.

Sandrine Funes1, Joseph A Hedrick, Shijun Yang, LiXin Shan, Marvin Bayne, Frederick J Monsma, Eric L Gustafson.   

Abstract

Neuromedin U (NmU) is a neuropeptide involved in various physiological functions such as feeding behavior, muscle contractile activity, and regulation of intestinal ion transport. Recently, two human G protein-coupled receptors have been identified as NmU-specific receptors, NmU-R1 and NmU-R2, which share 55% amino acid identity. It is unclear however, which of the two receptors mediates responses to NmU observed in rodent models. Attempts to define the pharmacological profile of the two receptors are confounded by overlapping expression of the two receptors and a lack of subtype-selective compounds. In order to establish a basis to further our understanding of the function of these receptors, we cloned and characterized the mouse homologues of the two human NmU receptors. Mouse NmU-R1 and mouse NmU-R2 are 79 and 81% identical to their respective human homologues. Expression of NmU-R1 was mainly observed in testis, gastrointestinal (GI) tract, and immune system, while NmU-R2 was primarily expressed in brain tissues. Each mouse receptor was independently expressed in HEK293 cells and demonstrated a dose-dependent calcium flux in response to NmU-8, NmU-23 and NmU-25. In an attempt to identify a synthetic NmU peptide that would exhibit selectivity at one of the two receptors, we examined the functional activity of eight alanine-substituted NmU-8 peptides. These experiments demonstrated that alanine substitution at positions 5 and 7 affects the functional activity of the peptide at both receptors. The arginine residue at position 7 is required for NmU-8 activity at either receptor while alanine substitution at position 5 selectively affects the potency and the efficacy at mNmU-R1. These experiments validate the use of rodent models to characterize NmU function relative to humans and suggest that substitution at Arginine-5 of NmU-8 may provide a receptor selective peptide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217421     DOI: 10.1016/s0196-9781(02)00097-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

Review 1.  Analysis of the network of feeding neuroregulators using the Allen Brain Atlas.

Authors:  Pawel K Olszewski; Jonathan Cedernaes; Fredrik Olsson; Allen S Levine; Helgi B Schiöth
Journal:  Neurosci Biobehav Rev       Date:  2008-03-29       Impact factor: 8.989

2.  The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Authors:  Julia E Gambone; Stephanie S Dusaban; Roxana Loperena; Yuji Nakata; Susan E Shetzline
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

3.  Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Authors:  Hongkui Zeng; Alexander Gragerov; John G Hohmann; Maria N Pavlova; Brian A Schimpf; Hui Xu; Long-Jun Wu; Hiroki Toyoda; Ming-Gao Zhao; Alex D Rohde; Galina Gragerova; Rene Onrust; John E Bergmann; Min Zhuo; George A Gaitanaris
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

4.  Small lipidated anti-obesity compounds derived from neuromedin U.

Authors:  Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Eur J Med Chem       Date:  2015-07-14       Impact factor: 6.514

Review 5.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

6.  Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.

Authors:  Clodagh E Prendergast; Magda F Morton; Katherine W Figueroa; Xiaodong Wu; Nigel P Shankley
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

7.  The neuropeptide neuromedin U promotes autoantibody-mediated arthritis.

Authors:  Sindhuja M Rao; Jennifer L Auger; Philippe Gaillard; Ralph Weissleder; Etsuko Wada; Richard Torres; Masayasu Kojima; Christophe Benoist; Diane Mathis; Bryce A Binstadt
Journal:  Arthritis Res Ther       Date:  2012-02-07       Impact factor: 5.156

8.  Overexpression of neuromedin U is correlated with regional metastasis of head and neck squamous cell carcinoma.

Authors:  Lei Wang; Chen Chen; Fen Li; Qing-Quan Hua; Shiming Chen; Bokui Xiao; Mengyuan Dai; Man Li; Anyuan Zheng; Di Yu; Zhang Wei Hu; Zezhang Tao
Journal:  Mol Med Rep       Date:  2016-05-27       Impact factor: 2.952

Review 9.  Neuromedin U: potential roles in immunity and inflammation.

Authors:  Yuan Ye; Zongan Liang; Luzheng Xue
Journal:  Immunology       Date:  2020-09-16       Impact factor: 7.397

10.  Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.

Authors:  Ludwik K Malendowicz; Agnieszka Ziolkowska; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.